Treatment of Subclinical Hyperthyroidism

Radiofrequency Ablation for Amiodarone-induced Thyrotoxicosis

NCT03720210 ·Status: TERMINATED ·Phase: NA

High Intensity Focused Ultrasound Device in Patients With Autonomous Hyperfunctioning Thyroid Nodules

NCT02169687 ·Status: TERMINATED ·Phase: EARLY_PHASE1

Phase 4 Study in Secondary Hypothyroidism: Body Weight Adapted Thyroxin Treatment and Triiodothyronine Supplementation

NCT00360074 ·Status: COMPLETED ·Phase: PHASE4

I-124 PET/CT Based Remnant Radioiodine Ablation Decision Concept in Differentiated Thyroid Cancer

NCT01704586 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

Does Radioiodine Treatment Prevent Atrial Fibrillation and Bone Loss in Endogenous Subclinical Hyperthyroidism?

NCT00151723 ·Status: UNKNOWN ·Phase: NA

Study Of AG-013736 In Patients With 131I-Refractory Thyroid Cancer

NCT00389441 ·Status: COMPLETED ·Phase: PHASE2

Clinical Study of Ultrasound-guided Radiofrequency Ablation in the Treatment of Refractory Hyperthyroidism

NCT06305871 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

ATX-GD-59 in Patients With Graves Disease Not Treated With Anti-thyroid Therapy

NCT02973802 ·Status: COMPLETED ·Phase: PHASE1

Block-replacement Therapy During Radioiodine Therapy

NCT00150124 ·Status: COMPLETED ·Phase: PHASE4

Thyroid Hormone Replacement for Subclinical Hypothyroidism and Dyslipidemia in ASCVD (ThyroHeart-Lipid Study)

NCT03606824 ·Status: UNKNOWN ·Phase: NA

Study of Resistance to Thyroid Hormone After Long-term Exposure in People With Thyroid Cancer

NCT04868045 ·Status: WITHDRAWN ·Phase: PHASE1

The TRUST Study - CardioVascular Imaging IMT

NCT02832934 ·Status: COMPLETED ·Phase: PHASE4

Medico-Economic Comparison of Four Strategies of Radioiodine Ablation in Thyroid Carcinoma Patients

NCT00435851 ·Status: UNKNOWN ·Phase: PHASE3

Thyroxine Replacement Therapy After Lobectomy for Low-risk Papillary Thyroid Carcinoma

NCT06087068 ·Status: RECRUITING ·Phase: PHASE2

Minimize Radioactive Iodine Ablation Of Remnant Thyroid in Differentiated Thyroid Cancer

NCT02418247 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease

NCT06727604 ·Status: RECRUITING ·Phase: PHASE2

Comparison of Different Doses of 131I in Severe Graves' Hyperthyroidism

NCT01039818 ·Status: COMPLETED ·Phase: PHASE3

Subtotal Versus Total Thyroidectomy for Graves' Disease

NCT01408368 ·Status: COMPLETED ·Phase: NA

Is Intraoperative PTH Monitoring Obsolete in Times of Choline PET/CT? a Prospective Multicenter Cohort Study to Determine Whether the Regular Preoperative Use of Choline-PET/CT Scan Obviate the Need for Intraoperative PTH-measurement in Patients with Primary Hyperparathyreoidism

NCT06804681 ·Status: NOT_YET_RECRUITING

Evaluation of the Clinical and Biological Consequences of Levothyrox® Formula Modification

NCT03569800 ·Status: TERMINATED

Low-dose Radioiodine Ablation in Graves' Disease

NCT03110835 ·Status: COMPLETED

Thyroid Hormone Replacement for Subclinical Hypothyroidism and Chronic Heart Failure (ThyroHeart-CHF)

NCT03096613 ·Status: UNKNOWN ·Phase: PHASE4

Thyroid Replacement Therapy in Patients With Subclinical Hypothyroidism

NCT04953195 ·Status: UNKNOWN ·Phase: PHASE4

Measuring Symptom Relief After Radiofrequency Ablation of the Thyroid

NCT05501041 ·Status: ENROLLING_BY_INVITATION

Determination of Pronostics Factors for Advanced Thyroid Carcinoma (pT3 pT4 or M1 at Diagnosis)

NCT02156362 ·Status: UNKNOWN ·Phase: NA